Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers
- PMID: 31837908
- DOI: 10.1016/j.tem.2019.11.005
Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers
Abstract
The tumor microenvironment (TME) is an attractive target to develop novel strategies for hormone-dependent cancers. Several molecules in the TME can favor tumor development and progression, including lipoproteins. Lipoproteins are taken up by cancer cells, providing them with cholesterol and fatty acids. Cholesterol regulates cell signaling and it is converted into a series of bioactive metabolites, including hormones. The conflicting results of epidemiological and interventional studies suggest that the local availability of lipoproteins in the TME is more relevant for cancer biology than their circulating levels. Thus, reducing lipoprotein uptake and stimulating cell cholesterol efflux to high-density lipoproteins (HDLs) can represent a novel adjuvant strategy for cancer management. HDL-like particles can also act as drug delivery systems for tumor targeting.
Keywords: breast cancer; lipoproteins; prostate cancer; tumor microenvironment.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
High-density lipoproteins: A promising tool against cancer.Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Jan;1867(1):159068. doi: 10.1016/j.bbalip.2021.159068. Epub 2021 Oct 13. Biochim Biophys Acta Mol Cell Biol Lipids. 2022. PMID: 34653581 Review.
-
Targeting HDL in tumor microenvironment: New hope for cancer therapy.J Cell Physiol. 2021 Nov;236(11):7853-7873. doi: 10.1002/jcp.30412. Epub 2021 May 21. J Cell Physiol. 2021. PMID: 34018609 Review.
-
Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.Curr Top Med Chem. 2020;20(30):2789-2800. doi: 10.2174/1568026620666201019111524. Curr Top Med Chem. 2020. PMID: 33076809 Review.
-
The role of high-density lipoproteins in antitumor drug delivery.IUBMB Life. 2019 Oct;71(10):1442-1452. doi: 10.1002/iub.2105. Epub 2019 Jul 10. IUBMB Life. 2019. PMID: 31290612 Review.
-
Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.Cancer Treat Res. 2015;166:129-50. doi: 10.1007/978-3-319-16555-4_6. Cancer Treat Res. 2015. PMID: 25895867 Free PMC article. Review.
Cited by
-
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study.Cancers (Basel). 2024 Apr 4;16(7):1411. doi: 10.3390/cancers16071411. Cancers (Basel). 2024. PMID: 38611089 Free PMC article.
-
A population-based cohort study of longitudinal change of high-density lipoprotein cholesterol impact on gastrointestinal cancer risk.Nat Commun. 2024 Apr 4;15(1):2923. doi: 10.1038/s41467-024-47193-9. Nat Commun. 2024. PMID: 38575589 Free PMC article.
-
Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort.Gastric Cancer. 2024 May;27(3):451-460. doi: 10.1007/s10120-024-01477-7. Epub 2024 Feb 28. Gastric Cancer. 2024. PMID: 38416240
-
Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer.iScience. 2023 May 19;26(6):106916. doi: 10.1016/j.isci.2023.106916. eCollection 2023 Jun 16. iScience. 2023. PMID: 37305703 Free PMC article.
-
New insights into lipid metabolism and prostate cancer (Review).Int J Oncol. 2023 Jun;62(6):74. doi: 10.3892/ijo.2023.5522. Epub 2023 May 19. Int J Oncol. 2023. PMID: 37203395 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources